(Q38061108)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23166150%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

review article

1 reference

title

Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23166150%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23166150%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Fabrice André

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23166150%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Javier Cortes

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23166150%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Carsten Denkert

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23166150%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Angelo Di Leo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23166150%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Sherene Loi

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23166150%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

7

B T Hennessy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23166150%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author name string

S Guiu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23166150%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

T Sorlie

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23166150%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

C Sotiriou

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23166150%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

N Turner

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23166150%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

M Van de Vijver

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23166150%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

G Viale

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23166150%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

J S Reis-Filho

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23166150%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

publication date

1 December 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23166150%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23166150%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23166150%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23166150%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

page(s)

2997-3006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23166150%20AND%20SRC:MED&resulttype=core&format=json

Histological and molecular types of breast cancer: is there a unifying taxonomy?

18 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS586

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS586

Trastuzumab in the adjuvant treatment of HER2-positive early breast cancer patients: a meta-analysis of published randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS586

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS586

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS586

The molecular portraits of breast tumors are conserved across microarray platforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS586

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS586

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS586

Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS586

Supervised risk predictor of breast cancer based on intrinsic subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS586

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS586

Identification of molecular apocrine breast tumours by microarray analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS586

An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS586

Gene expression profiling in breast cancer: classification, prognostication, and prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS586

Breast cancer molecular profiling with single sample predictors: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS586

Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS586

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS586

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS586

Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS586

Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS586

The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS586

Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS586

Breast cancer subtypes and the risk of local and regional relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS586

Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III tri

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS586

Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS586

Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS586

Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS586

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS586

Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS586

Conservation of breast cancer molecular subtypes and transcriptional patterns of tumor progression across distinct ethnic populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS586

Gene expression profiling identifies molecular subtypes of inflammatory breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS586

Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS586

Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS586

Agreement in breast cancer classification between microarray and quantitative reverse transcription PCR from fresh-frozen and formalin-fixed, paraffin-embedded tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS586

Microarray-based class discovery for molecular classification of breast cancer: analysis of interobserver agreement

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS586

Systematic bias in genomic classification due to contaminating non-neoplastic tissue in breast tumor samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS586

A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS586

Responsiveness of intrinsic subtypes to adjuvant anthracycline substitution in the NCIC.CTG MA.5 randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS586